Obstructing Colorectal Cancer Clinical Trial
Official title:
Preoperative Assessment for Synchronous Carcinoma or Polyps With MR Colonography in Patients With Obstructing Cancer. A Prospective Study.
| Verified date | March 2006 |
| Source | Herlev Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Denmark: National Board of Health |
| Study type | Interventional |
The purpose of this study is to diagnose possible synchronous carcinomas and polyps with magnetic resonance (MR) colonography in patients booked for operation because of carcinoma in the descending or sigmoid colon, where a preoperative full colonoscopy is not possible. Two days before colonography, patients ingest a 200 ml Barium sulfate solution four times a day, which will render fecal masses "invisible" on the following MR colonography. The study is primarily a feasibility study with altered operative strategy as a secondary end-point. Gold standard is colonoscopy and operation.
| Status | Completed |
| Enrollment | 50 |
| Est. completion date | |
| Est. primary completion date | April 2008 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Obstructing colorectal cancer Exclusion Criteria: - Suspicion of IBD - Pacemaker - Metal in the body - Claustrophobia - Pregnancy |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Country | Name | City | State |
|---|---|---|---|
| Denmark | Department of Radiology Copenhagen University Hospital Herlev | Copenhagen |
| Lead Sponsor | Collaborator |
|---|---|
| Herlev Hospital | University Hospital, Gentofte, Copenhagen |
Denmark,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Feasibility of MR colonography to diagnose possible synchronous carcinomas and polyps | 3 | No | |
| Secondary | Altered operative strategy due to findings on MR colonography | 3 | No |